ARTELO BIOSCIENCES, INC. - ARTL
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q2 2026
· Q1 2026
Value (USD)
Total reported value ($000)
$129K
QoQ value delta ($000)
-$697K
(-84.38%)
Implied price effect (QoQ)
-93.8%
Shares
Total shares
117,118
QoQ shares delta
+70,626
(+151.91%)
Total shares held by funds (by quarter)
Market chart (ARTL)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q2 2026)
Top 25 only
Full list
Partial Q2 2026 data: 10 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| JANE STREET GROUP, LLC | 74 | 66,341 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 15 | 13,864 | 0.0% |
| StoneX Group Inc. | 14 | 12,400 | 0.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 11 | 10,129 | 0.0% |
| Tower Research Capital LLC (TRC) | 9 | 8,435 | 0.0% |
| VANGUARD FIDUCIARY TRUST CO | 3 | 3,139 | 0.0% |
| UBS Group AG | 3 | 2,804 | 0.0% |
| ROTHSCHILD INVESTMENT LLC | 0 | 2 | 0.0% |
| CWM, LLC | 0 | 1 | 0.0% |
| DANSKE BANK A/S | 0 | 1 | 0.0% |
| TD Waterhouse Canada Inc. | 0 | 2 | 0.0% |